Invasight AG

ACINDA

Software; Software for a database; Software for a database for oncology research; Electronic database for oncology research, particularly anti-cancer treatments;Hosting of databases; Hosting and development of data bases for research on anti-cancer treatments; Software as a Service (SaaS) featuring databank for oncology research; Hosting, Programming and Development of a drug discovery and development platform; Online data storage; Providing of access to a database for scientific and medical services; Consultancy and assistance in the medical sciences via an online platform; Hosting of an online platform for the archiving, evaluation, analysation and exchange of data in the fields of biological research, clinical research and medical research; Software as a service (SaaS) services featuring software for machine learning, deep learning and deep neural networks, all of the given services particularly for oncology research;

INVASIGHT

Scientific apparatus and instruments for research in laboratories; Scientific apparatus and instruments for research in laboratories, particularly in the field of oncology and cancer treatment and prevention; Data processing equipment for research in the field of oncology; Electronic database for oncology research, particularly anti-cancer treatments; Software; Software for a database; Software for a database for oncology research;Pharmaceuticals; Pharmaceutical preparations; Pharmaceutical and veterinary preparations and substances; preparations for healthcare; chemicals and chemical preparations and substances used for medical and pharmaceutical purposes and in medicines; dietetic substances for medical purposes; foods and beverages for babies, infants or invalids; vitamins; Anti-cancer drugs; Compounds for treating cancer, particularly anti-cancer invasion drugs; Diagnostic kits for research in the field of oncology, particularly cancer cell migration and invasion;Medical research; Pharmaceutical products development, particularly in the field of oncology; Scientific research in the field of chemistry, biochemistry and biology; Scientific research for medical purposes in the area of cancerous diseases; Research and development of vaccines and medicines, particularly anti-cancer invasion treatments; Hosting of a database; Hosting of a database for scientific research for medical purposes in the area of cancerous diseases; Hosting and development of data bases for research on anti-cancer treatments; Software as a Service (SaaS) featuring databank for oncology research; Design and development of computer hardware and software relating to research and development in the area of oncology; Hosting, Programming and Development of a drug discovery and development platform; Online data storage; Providing of access to a database for scientific and medical services; Consultancy and assistance in the medical sciences via an online platform; Hosting of an online platform for the archiving, evaluation, analysation and exchange of data in the fields of biological research, clinical research and medical research; Software as a service (SaaS) services featuring software for machine learning, deep learning and deep neural networks, all of the given services particularly for oncology research;

INVASIGHT

The mark consists of the stylized wording INVASIGHT; to the left of this appears a circular design having a dot in its center with broken outer line in the upper right and lower left portions.;Scientific apparatus and instruments for research in laboratories; Scientific apparatus and instruments for research in laboratories, particularly in the field of oncology and cancer treatment and prevention; Data processing equipment for research in the field of oncology; Electronic database for oncology research, particularly anti-cancer treatments; Software; Software for a database; Software for a database for oncology research;Pharmaceuticals; Pharmaceutical preparations; Pharmaceutical and veterinary preparations and substances; preparations for healthcare; chemicals and chemical preparations and substances used for medical and pharmaceutical purposes and in medicines; dietetic substances for medical purposes; foods and beverages for babies, infants or invalids; vitamins; Anti-cancer drugs; Compounds for treating cancer, particularly anti-cancer invasion drugs; Diagnostic kits for research in the field of oncology, particularly cancer cell migration and invasion;Color is not claimed as a feature of the mark.;Medical research; Pharmaceutical products development, particularly in the field of oncology; Scientific research in the field of chemistry, biochemistry and biology; Scientific research for medical purposes in the area of cancerous diseases; Research and development of vaccines and medicines, particularly anti-cancer invasion treatments; Hosting of a database; Hosting of a database for scientific research for medical purposes in the area of cancerous diseases; Hosting and development of data bases for research on anti-cancer treatments; Software as a Service (SaaS) featuring databank for oncology research; Design and development of computer hardware and software relating to research and development in the area of oncology; Hosting, Programming and Development of a drug discovery and development platform; Online data storage; Providing of access to a database for scientific and medical services; Consultancy and assistance in the medical sciences via an online platform; Hosting of an online platform for the archiving, evaluation, analysation and exchange of data in the fields of biological research, clinical research and medical research; Software as a service (SaaS) services featuring software for machine learning, deep learning and deep neural networks, all of the given services particularly for oncology research;